Skip to main content
. Author manuscript; available in PMC: 2009 Jul 13.
Published in final edited form as: J Neurol. 2005 Apr 29;252(9):1082–1092. doi: 10.1007/s00415-005-0819-7

Table 4.

Table 4a Region of Interest Analysis: Group Mean and SD of metabolites and GM
Group Region % GM in ROI Mean (SD) NAA Mean (SD) Cr Mean (SD) Cho Mean (SD) NAA/Cr Mean (SD) NAA/Cho Mean (SD)
Controls Mixed GM + WM for Lesion 39.49 (13.17) 1.68 (0.18) 0.82 (0.05) 0.21 (0.03) 2.09 (0.22) 8.76 (1.66)
Mixed GM + WM for Perilesion 38.45 (12.75) 1.67 (0.16) 0.78 (0.06) 0.22 (0.04) 2.22 (0.16) 8.59 (1.99)
Patients Lesion 39.85 (15.49) 1.51 (0.28) 0.74 (0.19) 0.20 (0.07) 2.11 (0.41) 8.24 (2.45)
Perilesion 34.24 (12.19) 1.52 (0.32) 0.74 (0.19) 0.21 (0.07) 2.12 (0.54) 8.82 (5.11)
Table 4b ROI: Significant Metabolical Abnormalities Found in Individual Patients
Patient No Radiological classification Metabolic Abnormality
Malformation Perilesional zone
1 heterotopia, polymicrogyria NAA ↓, NAA/Cr no
2 cortical dysplasia no NAA/Cr
3 heterotopia, polymicrogyria no no
4 R F transmantle dysplasia NAA no
L P transmantle dysplasia na no
R P transmantle dysplasia na no
5 heterotopia, polymicrogyria no NAA
6 polymicrogyria no no
7 cortical dysplasia Cho no
8 heterotopia, polymicrogyria no no

Mixed GM + WM: Voxels in controls were selected to match lobe and tissue composition of the malformation and perilesional region of each patient

There were no differences between the groups. NAA lesion showed a tendency to be lower (p = 0.06)

significant; 2 SD below or above mean in corresponding regions (lobe and matched for tissue composition) of controls

no within control range; na not available